Literature DB >> 28259609

Targeted therapy of pancreatic cancer: biomarkers are needed.

Jörg Kleeff1, Patrick Michl2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28259609     DOI： 10.1016/S1470-2045(17)30087-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.

Authors:  Nalin C W Goonesekere; Wyatt Andersen; Alex Smith; Xiaosheng Wang
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-29       Impact factor: 4.553

2.  Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer.

Authors:  Fan Yang; Dong-Yan Liu; Jin-Tao Guo; Nan Ge; Ping Zhu; Xiang Liu; Sheng Wang; Guo-Xin Wang; Si-Yu Sun
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

3.  WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness.

Authors:  Hengchao Li; Xiaohui Liu; Shuheng Jiang; Xinwen Zhou; Lie Yao; Yang Di; Yongjian Jiang; Jichun Gu; Yishen Mao; Ji Li; Chen Jin; Pengyuan Yang; Deliang Fu
Journal:  Br J Cancer       Date:  2020-06-30       Impact factor: 7.640

4.  Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma.

Authors:  Lili Zhao; Bingrong Liu
Journal:  Oncotarget       Date:  2017-10-10

5.  Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.

Authors:  Liang Cheng; Bin Yan; Ke Chen; Zhengdong Jiang; Cancan Zhou; Junyu Cao; Weikun Qian; Jie Li; Liankang Sun; Jiguang Ma; Qingyong Ma; Huanchen Sha
Journal:  Oxid Med Cell Longev       Date:  2018-03-22       Impact factor: 6.543

6.  Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.

Authors:  Jun-Dong Du; Xi Zheng; Yong-Liang Chen; Zhi-Qiang Huang; Shou-Wang Cai; Hua-Bo Jiao; Zi-Man Zhu; Bin Hu
Journal:  Med Sci Monit       Date:  2018-06-03

7.  N-Dihydrogalactochitosan Potentiates the Radiosensitivity of Liver Metastatic Tumor Cells Originated from Murine Breast Tumors.

Authors:  Chung-Yih Wang; Chun-Yuan Chang; Chun-Yu Wang; Kaili Liu; Chia-Yun Kang; Yi-Jang Lee; Wei R Chen
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

8.  The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer.

Authors:  Zachary Heinzman; Connor Schmidt; Marek K Sliwinski; Nalin C W Goonesekere
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-03

9.  Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest.

Authors:  Huanyu Zhang; Zhe Zhang; Yonghao Huang; Siyuan Qin; Li Zhou; Ningna Weng; Jiayang Liu; Mei Yang; Xiaodian Zhang; Yanda Lu; Lin Ma; Shaojiang Zheng; Qifu Li
Journal:  Mol Oncol       Date:  2020-12-12       Impact factor: 7.449
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.